Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Canadian Natural Resources Ltd. (CNQ) vs TransMedics Group Inc (TMDX) Price & Performance

Canadian Natural Resources Ltd.Trade
TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Canadian Natural Resources Ltd. vs TransMedics Group Inc — how do they compare? Canadian Natural Resources Ltd. trades at $42.83 (market cap $88.15B), while TransMedics Group Inc trades at $75.29 (market cap $2.58B). The key difference: Canadian Natural Resources Ltd. is far larger — about 34.2× TransMedics Group Inc's market cap, and Canadian Natural Resources Ltd. pays a 4.13% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

CNQTMDX
Market Cap
$88.15B$2.58B
Sector
EnergyTechnology
52-Week High
$50.55$150.42
52-Week Low
$29.31$61.99
Enterprise Value
$99.38B$2.98B
Dividend Yield
4.13%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Canadian Natural Resources Ltd.

CNQ trades at $43.05, up 2.97% today, with a bullish technical signal supported by moving averages and ADX. The stock shows strong fundamentals with a P/E of 11.8, net income margin of 24.5%, and consistent earnings beats in recent quarters. Recent news highlights its robust asset base and operational efficiency amid volatile oil markets. Cash flow remains positive, with 2025 net cash flow at $542 million.

Outlook is positive with analyst consensus strongly favoring Buy (75%), driven by valuation appeal and shareholder returns via dividends and buybacks. Key risks include oil price volatility and rising debt-to-asset ratio, which increased to 22.04% in 2024. The stock's proximity to its 52-week high suggests cautious optimism, but fundamentals support long-term growth potential.

TransMedics Group Inc

TransMedics (TMDX) trades at $75.74, up 6.33% today, showing strong momentum despite a recent earnings miss. The stock maintains bullish technical signals with support at $75 and resistance at $77. Recent strategic investments in European organ logistics through PAD Aviation position the company for international expansion, though margin pressure from these investments remains a concern. Analyst consensus remains strongly positive with a $108.71 price target.

The outlook remains favorable with 75% analyst buy ratings and significant upside potential from current levels. Key risks include execution challenges in European expansion, ongoing margin pressure from NOP investments, and competitive threats in the transplant logistics space. Revenue growth continues at 21% year-over-year, but investors should monitor margin trends and European rollout execution closely.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Canadian Natural Resources Ltd.

Canadian Natural Resources is one of the largest oil and natural gas producers in western Canada, supplemented by operations in the North Sea and Offshore Africa. The company's portfolio includes light and medium oil, heavy oil, bitumen, synthetic oil, natural gas liquids, and natural gas. Production averaged 1.16 million barrels of oil equivalent per day in 2020, and the company estimates that it holds over 11.5 billion boe of proven and probable crude oil and natural gas reserves.

Read more on CNQ

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.

Read more on TMDX